Full-Time

VP – Market Access & Value-Based Partnerships

Confirmed live in the last 24 hours

Rune Labs

Rune Labs

51-200 employees

Develops software for neuromodulation applications

Compensation Overview

$250k - $300k/yr

+ Equity + Bonus up to 35%

Senior, Expert

San Francisco, CA, USA

Remote work is considered for exceptional candidates with regular travel to San Francisco.

Category
Strategy Development
Business & Strategy
Required Skills
Financial Modeling
Connection
Connection
Connection
logo

Get referrals →

You have ways to get a Rune Labs referral from your network.

💡

Applications through a referral are 3x more likely to get an interview!

Requirements
  • 12+ years of experience in healthcare market access, with at least 5 years focused on value-based care models
  • Proven track record structuring and implementing risk-sharing agreements with health systems
  • Deep understanding of Medicare Advantage and ACO payment models
  • Experience launching and scaling digital health or therapeutic products
  • Strong analytical skills and ability to build financial models for various payment structures
  • Excellence in executive-level communications and presentations
  • Bachelor's degree required; MBA or related advanced degree preferred
  • Possess current U.S. work authorization
Responsibilities
  • Design and execute comprehensive market access strategy across payer segments
  • Lead pricing and contracting strategy for different customer segments and payment models
  • Build and lead a high-performing market access team
  • Serve as a key member of the senior leadership team
  • Leverage Kaiser Permanente results to develop compelling value propositions for integrated health systems and risk-bearing entities
  • Structure and negotiate value-based contracts with healthcare organizations
  • Design innovative risk-sharing models that align with customer needs and Rune Labs' capabilities
  • Develop frameworks for measuring and reporting on value-based care outcomes
  • Identify and develop new market access channels, including direct-to-consumer strategies
  • Create pricing models that work across different payment types (value-based, fee-for-service, cash pay)
  • Partner with product team to ensure market access requirements are reflected in product roadmap
  • Collaborate with clinical teams to generate evidence supporting market access strategies
  • Build relationships with key decision makers at target healthcare organizations
  • Work with government affairs team on relevant policy initiatives
  • Collaborate with marketing to develop market access materials and value propositions
  • Partner with finance team on pricing models and revenue forecasting
Desired Qualifications
  • Background working with movement disorder or neurology products/services
  • Experience with direct-to-consumer healthcare business models
  • Knowledge of Parkinson's disease care delivery and economics
  • Track record of working with both regional and national health plans
  • Understanding of digital health reimbursement landscape
  • Experience building and leading market access teams

Rune Labs develops software solutions for neuromodulation applications aimed at treating chronic neurological diseases like Parkinson's, epilepsy, and Alzheimer's. Their software is designed to work with brain-machine interfaces, which help restore mobility to paralyzed patients, accelerate stroke recovery, and potentially improve cognitive functions and mood. Unlike many competitors, Rune Labs focuses specifically on the intersection of software and neuromodulation technology, catering to medical researchers, healthcare providers, and patients. The company's goal is to enhance the quality of life for individuals with neurological conditions through advanced technology.

Company Size

51-200

Company Stage

Early VC

Total Funding

$41.3M

Headquarters

San Francisco, null

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for wearable health tech boosts Rune Labs' StrivePD platform.
  • Partnerships with tech giants like Apple enhance data collection capabilities.
  • Rising interest in real-world evidence supports Rune Labs' StriveStudy platform.

What critics are saying

  • Increased competition from digital health platforms may impact market share.
  • Rapid AI advancements require constant software updates, straining resources.
  • Data privacy concerns could lead to regulatory scrutiny affecting operations.

What makes Rune Labs unique

  • Rune Labs integrates with Apple Watch for real-time Parkinson's symptom tracking.
  • Their StriveStudy platform offers remote data collection for clinical trials.
  • Rune Labs focuses on AI-driven care management for personalized neurology treatments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Remote Work Options

401(k) Company Match

Performance Bonus

Equity eligible

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

0%

2 year growth

1%
Business Wire
Mar 5th, 2025
Rune Labs Launches AI and Personalized Coaching Care Management Service for Parkinson's Disease

Rune Labs launches AI and Personalized Coaching care management service for Parkinson's Disease.

Business Wire
Sep 5th, 2024
Rune Labs Launches GenAI Clinical Support to Accelerate Care Management for Parkinson's Patients and Clinicians

Rune Labs launches GenAI clinical support to accelerate care management for Parkinson's patients and clinicians.

Business Wire
Jan 12th, 2024
Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson’s Technologies

Rune Labs, a precision neurology software and data company, today announced a strategic round of $12 million, increasing the total amount raised by th

Stat News
Jan 11th, 2024
Rune Labs, which makes an app to track Parkinson's symptoms, raises $12 million

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson's disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Valdosta Daily Times
Jan 11th, 2024
Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson's Technologies

Jordi Parramon, PhD, CEO, General Partner and Co-Founder of Nexus NeuroTech Ventures and former President of Medical Devices at Verily, will join Rune Labs' board of directors.